At Bayesian Health, our mission is to make healthcare proactive by equipping physicians and care teams with accurate, actionable clinical signals derived from comprehensive patient data. Founded in 2021, our platform integrates advanced AI and machine learning models licensed from Johns Hopkins University, ensuring a solid research-based foundation supported by over 21 patents and numerous peer-reviewed publications. We embed our clinical decision support system seamlessly within electronic medical records (EMR), enabling real-time, workflow-compatible delivery of insights that help catch life-threatening events early and allow for timely, effective interventions.
We focus on critical areas such as clinical deterioration, sepsis, pressure injury prevention, and transitions of care. By leveraging adaptive AI technology, our solution delivers high-quality information that enhances physician prognostication and supports proactive care at scale, ultimately improving patient outcomes and reducing healthcare costs. Our approach is deeply rooted in multidisciplinary academic and clinical research, resulting in sustained health and financial improvements across health systems.
With $15 million in venture funding led by Andreessen Horowitz and participation from other key investors, Bayesian Health continues to advance the frontier of clinical AI augmentation. Our commitment extends beyond technology—we ensure that our platform’s deployment translates into measurable clinical impact and financial return for healthcare organizations. We believe data in healthcare must be intelligently organized and interpreted to truly transform care delivery.
We invite healthcare providers to explore how Bayesian Health’s AI platform can augment clinical decision-making and usher in a new era of intelligent, proactive care. Through continuous innovation and collaboration, we aim to empower caregivers with the tools to deliver safer, more precise, and timely healthcare interventions for all patients.